Cours Isodiol International Inc Canadian Securities Exchange
Actions
CA46500L1013
Produits pharmaceutiques
CA 2018 | 19,14 M 26,09 M 17,15 M | CA 2019 | 22,25 M 30,33 M 19,94 M | Capitalisation | 49,96 M 68,11 M 44,78 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -49,08 M -32,27 M | Résultat net 2019 | -126 M -172 M -113 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 21,2 M 13,94 M | Dette nette 2019 | 5,22 M 7,12 M 4,68 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+27,19% | 5,36 Md | |
-33,59% | 3,4 Md | |
-2,97% | 2,9 Md | |
-24,21% | 2,53 Md | |
-10,11% | 2,27 Md | |
+43,66% | 1,84 Md | |
+46,15% | 1,42 Md | |
+41,90% | 1,38 Md | |
-13,92% | 1,37 Md |